¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inflammatory linear verrucous epidermal nevus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • inflammatory mediator
    ¿°Áõ¸Å°³Ã¼, ¿°Áõ¸Å°³¹°
  • inflammatory pseudotumor
    ¿°Áõ°ÅÁþÁ¾¾ç
  • inflammatory response
    ¿°Áõ¹ÝÀÀ
  • pelvic inflammatory disease
    °ñ¹Ý¿°ÁõÁúȯ, °ñ¹Ý¿°
  • systemic inflammatory response syndrome
    Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
  • general linear model
    ÀϹݼ±Çü¸ðµ¨
  • linear
    ÁÙ(¸ð¾ç)-, ¼±Çü-, ¼±»ó-
  • linear acceleration
    ¼±Çü°¡¼Óµµ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear attenuation coefficient
    ¼±Çü°¨¼è°è¼ö
  • linear correlation
    ¼±Çü»ó°ü
  • linear density
    ¼±À½¿µ
  • linear electronic scanner
    ¼±ÀüÀڽĽºÄ³³Ê
  • linear fracture
    ¼±°ñÀý, ¼±»ó°ñÀý
  • linear molecule
    ¼±ÇüºÐÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
  • inflammatory erythema
    ¿°ÁõÈ«¹Ý
  • inflammatory fracture
    ¿°Áõ°ñÀý
  • inflammatory gangrene
    ¿°Áõ±«Àú
  • inflammatory
    ¿°Áõ-
  • inflammatory lesion
    ¿°Áõº´ÅÍ, ¿°ÁõȯºÎ
  • inflammatory mediator
    ¿°Áõ¸Å°³Ã¼
  • inflammatory response
    ¿°Áõ¹ÝÀÀ
  • inflammatory trismus
    ¿°ÁõÀÔ¹ú¸²Àå¾Ö, ¿°Áõ°³±¸Àå¾Ö
  • linear acceleration
    ¼±Çü°¡¼Ó
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear phased array
    ÁÙÀ§»óÂ÷¹è¿­
  • linear sequenced array
    ÁÙ¸ð¾ç¼ø¼­¹è¿­, ¼±Çü¼øÂ÷¹è¿­
  • linear switched array
    ÁÙ±³´ë½Ä¹è¿­
  • linear correlation
    ¼±»ó»ó°ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pigmented nevus
    »ö¼Ò¸ð¹Ý
  • pigmented nevus
    »ö¼Ò¼º ¸ð¹Ý(ßäáÈàõÙ½Úè)
  • porokeratotoic eccrine ostial and dermal duct nevus
    ÇѰø°¢È­Áõ¼º ¿¡Å©¸°±¸¸Û ¹× ÁøÇǰü¸ð¹Ý
  • port-wine stain = nevus flammeus
    ºÒ²É¸ð¹Ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • verrucous melanoma
    »ç¸¶±Í¾ç ¾Ç¼ºÈæ»öÁ¾
  • verrucous nevi
    »ç¸¶±Í»ó¸ð¹Ý
  • verrucous nevi
    »ç¸¶±Í»ó¸ð¹Ý(¡­Ù½Úè)
  • verrucous vegetation
    »ç¸¶±Í»óÁõ½Ä¹°(¡­ñòãÖÚª)
  • verrucous xanthoma
    »ç¸¶±Í¾ç Ȳ»öÁ¾
  • acute inflammatory demyeliniating
    ±Þ¼º¿°Áõ¼ºÅ»¼öÃʼº(¡­æúñøàõ ÷­âÐÃÊàõ)
  • anti-inflammatory
    Ç׿°Áõ¼º(ù÷æúñøàõ)ÀÇ.
  • anti-inflammatory
    Ç׿°(Áõ)¼º
  • anti-inflammatory agent
    Ç׿°Áõ¾à(ù÷æúñøå·).
  • cell, inflammatory
    ¿°Áõ¼¼Æ÷
  • cervical inflammatory ectropium
    ¿°Áõ¼º °æ°üÁ¡¸·¿Ü¹ÝÁõ(æúñøàõÌòηïÄØ¯èâÚãñø).
  • chronic inflammatory demyelinating polyradiculoneuropathy
    ¸¸¼º¿°Áõ¼ºÅ»¼öÃʴٹ߼º½Å°æº´Áõ(¡­æúñúàõ÷­âÐÃÊÒýÛ¡àõãêÌèÜ»ñø)
  • edema,inflammatory
    ¿°Áõ¼º(æúñøàõ)
  • inflammatory bowel disease
    ¿°Áõ¼º ÀåÁúȯ
  • inflammatory bowel disease
    ¿°Áõ¼º ÀåÁúȯ(¡­ íóòðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • phased linear array type
    À§»óÂ÷¼±Çü¹è¿­½Ä
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LTN lateral telangiectatic nevus
MN a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt...
NC nasal cannula; nasal clearance; neck complaint; neonatal cholestasis; neural crest; neurologic check...
NN neonatal; nevocellular nevus; normally nourished; normal nutrition; nurse's notes
NSJ nevus sebaceus of Jadassohn
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LET High-linear energy transfer
LINAC Linear Accelerator
LAS Linear Alkylbenzene Sulphonate
LASA Linear Analogue Self Assessment
LDA Linear Discriminant Analysis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • peripheral linear enhancement
    ¸»ÃÊ ¼±Çü Á¶¿µ Áõ°­
  • acute inflammatory demyelinating polyradiculoneuropathy
    ±Þ¼º ¿°Áõ¼º ´Ù¹ß½Å°æ¿°
    ¾ÆÁ÷µµ È®½ÇÇÏÁö ¾ÊÁö¸¸ ¸é¿ª¹ÝÀÀÀ» ÅëÇÏ¿© ³ªÅ¸³­´Ù°í ¾Ë·ÁÁ® ÀÖ´Â ½Å°æº´ÁõÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ±Þ¼ÓÈ÷ ÁøÇàÇÏ´Â ¿îµ¿½Å°æº´ÁõÀ¸·Î ÇÏÁö¿¡¼­ ½ÃÀÛÇÏ¿© »óÁö·Î ÁøÇàµÇ¸ç, Á¤µµÀÇ Â÷À̸¦ °¡Áø °¨°¢Àå¾Ö¸¦ µ¿¹ÝÇÑ´Ù.
  • anti-inflammatory
    Ç׿°Áõ¾à, Ç׿°ÁõÀÇ, Ç׿°Áõ¼ºÀÇ
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â.
  • anti-inflammatory agent
    Ç׿°Áõ ¾à, ¼Ò¿°Á¦, Ç׿°ÁõÁ¦
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦.
  • chronic inflammatory trismus
    ¸¸¼º ¿°Áõ¼º ¾Æ°ü±ä±Þ
  • fibrous inflammatory hyperplasia
    ¼¶À¯ ¿°Áõ¼º °úÇü¼º
  • heavier inflammatory component
    ´õ ½ÉÇÑ ¿°Áõ ¿äÀÎ
  • inflammatory
    ¿°Áõ¼º
    ¿°Áõ°ú °ü·ÃµÈ.
  • inflammatory by-product
    ¿°Áõ ºÎ»ê¹°
  • inflammatory cell infiltration
    ¿°Áõ ¼¼Æ÷ÀÇ Ä§À±
    ¿°ÁõÀ» ÀÏÀ¸Å°¸é »ýü´Â ¹æ¾îÀûÀ¸·Î Ȱµ¿ÇÏ°í ¿°Áõ ¹°ÁúÀÇ Á¦°Å, ¿°ÁõÀÇ ÁøÀüÀ» ÀúÁöÇϱâ À§ÇØ ÁÖ·Î Ç÷¾×ÁßÀÇ ¹éÇ÷±¸
  • inflammatory change
    ¿°Áõ º¯È­, ¿°Áõ¼º º¯È­
  • inflammatory diarrhea
    ¿°Áõ¼º ¼³»ç
  • inflammatory disorder
    ¿°Áõ¼º Àå¾Ö
  • inflammatory erythema
    ¿°Áõ¼º È«¹Ý
  • inflammatory gingival hyperplasia
    ¿°Áõ¼º Ä¡Àº Áõ½Ä
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
linear acceleration The rate of change of velocity without a change in direction; e.g., when the speed of an aircraft increases while flying a straight pathway.
(05 Mar 2000)
linear accelerator <apparatus> A sophisticated external beam radiotherapy machine which has the capabilities of focussing irradiation (although not very finely).
Acronym: LinAC
(16 Dec 1997)
linear amputation Amputation performed by a circular incision through the skin, the muscles being similarly divided higher up, and the bone higher still.
Synonym: guillotine amputation, linear amputation.
(05 Mar 2000)
linear atrophy Bands of thin wrinkled skin, initially red but becoming purple and white, which occur commonly on the abdomen, buttocks, and thighs at puberty and/or during and following pregnancy, and result from atrophy of the dermis and overextension of the skin; also associated with ascites and Cushing's syndrome.
Synonym: atrophoderma striatum, lineae albicantes, lineae atrophicae, linear atrophy, stretch marks, stria, striae atrophicae, striate atrophy of skin, traction atrophy, vergeture.
(05 Mar 2000)
linear dichroism <chemistry> Differential absorption of right hand and left hand circularly polarized light resulting from molecular asymmetry involving a chromophore group. Circular dichroism is used to study the conformation of proteins in solution.
(18 Nov 1997)
linear energy transfer <radiobiology> Average amount of energy lost per unit of particle track length and expressed in keV um-1.
Acronym: LET
(16 Dec 1997)
linear fracture A fracture running parallel with the long axis of the bone.
Synonym: fissured fracture.
(05 Mar 2000)
linear IgA bullous disease in children A rare self-limiting bullous disease, chiefly of the trunk, perioral, and pelvic areas, with onset in the first decade, successively less severe recurrences, and total remission at adolescence; linear epidermal basement membrane zone deposit of IgA is found in involved and in normal skin.
Synonym: linear IgA bullous disease in children.
(05 Mar 2000)
linear models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
(12 Dec 1998)
linear skull fracture A skull fracture resembling a line.
(05 Mar 2000)
acute inflammatory polyneuropathy <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin.
The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months.
Synonym: Guillain-Barre syndrome
(12 Jul 2000)
anti-inflammatory Counteracting or suppressing inflammation.
(18 Nov 1997)
anti-inflammatory agent Agents that counteract or suppress the inflammatory process. An antirheumatic agent or inflammation mediator, both endogenous and exogenous substances used to counteract the inflammatory process or alleviate or prevent rheumatic diseases, and the compounds that mediate the inflammation process.
(12 Dec 1998)
anti-inflammatory agent, non-steroidal Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain nsaids also may inhibit lipoxygenase enzymes or phospholipase c or may modulate T-cell function. (ama drug evaluations annual, 1994, p 1814-5)
(12 Dec 1998)
anti-inflammatory agent, steroidal Steroidal agents capable of suppressing or counteracting the inflammatory process by acting on body mechanisms, without directly antagonizing the causative agents.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á